Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Camphor/menthol OTC antitussive revised flammability warnings proposed.

This article was originally published in The Tan Sheet

Executive Summary

CAMPHOR/MENTHOL TOPICAL/INHALANT PRODUCTS REVISED BURN WARNING concerning the dangers of using the OTC antitussives near an open flame, in hot water or in a microwave oven are proposed by FDA as an amendment to the 1987 final monograph in a notice slated for publication in the July 20 Federal Register. The agency is basing the need for the revised warning on 34 reports of fire-related events between 1983 and mid-1997 that led to burns caused by flashing from the use of antitussives formulated with camphor and/or menthol. FDA is seeking comments on the proposal up to 90 days post-publication and estimates a 12-month implementation for the changes.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS088663

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel